Search results for “Breast cancer metastasis” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 148 patents, we discovered top 56 key players by total patent application. OncoTherapy Science, Inc., Human Genome Sciences, Inc., Celera Corp. are dominant in this area. They take 35.14% of the total patent filing.
Kanagawa-ken, Japan
Patent: 21
United States
Patent: 16
California, United States
Patent: 10
New Jersey, United States
Patent: 8
South Korea
Patent: 6
Hokkaido, Japan
Patent: 5
Connecticut, United States
Patent: 4
South Korea
Patent: 3
New Jersey, United States
Patent: 3
Jiangsu Sheng, China
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 98 patents applied in the last 5 years. We discover 66 most active companies in this area. The fast-growing Seoul University Industry Academic Cooperation Foundation, Academia Sinica, MSD International GmbH take 11.22% of patent filing during this period.
South Korea
Patent: 4
China
Patent: 4
Singapore
Patent: 3
South Korea
Patent: 3
Noord-Brabant, Netherlands
Patent: 3
undefined undefined
Patent: 3
Guangdong Sheng, China
Patent: 3
Jiangsu Sheng, China
Patent: 2
South Korea
Patent: 2
Beijing Shi, China
Patent: 2
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 98 patents in last 5 years, we discover 52 new entrants. MSD International GmbH, PharmAbcine Inc., Merck Sharp & Dohme BV are the most active new entrants in this area.
Singapore
Patent: 3
South Korea
Patent: 3
Noord-Brabant, Netherlands
Patent: 3
undefined undefined
Patent: 3
South Korea
Patent: 2
Beijing Shi, China
Patent: 2
United States
Patent: 2
Shanghai Shi, China
Patent: 2
China
Patent: 2
Henan Sheng, China
Patent: 2
Research Institutions
Order by:
Innovation Intensity
With the analysis among 204 patents, we discovered top 47 universities and scientific research institutions by total patent application. Nankai University, The University of Liverpool, National University of Singapore are dominant in this area. They take 12.25% of the total patent filing.
Tianjin Shi, China
Patent: 9
CITY OF LIVERPOOL, United Kingdom
Patent: 6
Central Region, Singapore
Patent: 4
Tokyo-to, Japan
Patent: 4
Baden-Württemberg, Germany
Patent: 4
Tianjin Shi, China
Patent: 3
Ireland
Patent: 3
Jiangsu Sheng, China
Patent: 3
United States
Patent: 2
Shanghai Shi, China
Patent: 2
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: